Existing user? Login

Retigabine approved for epilepsy

By News Team

Retigabine has been approved for controlling seizures in adults with epilepsy by the National Institute for Health and Clinical Excellence.

New published this week (27 July 2011) recommends retigabine (Trobolt; GlaxoSmithKline) treatment for adults with partial onset seizures (with or without secondary generalisation) as an add-on treatment option.  

Patients should only be treated with retigabine if the following drugs have been ineffective or caused unmanageable side effects: carbamazepine, clobazam, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, sodium valproate and topiramate.


Citation: Electronicjuice URI: 11081422

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.